CDC cuts childhood vaccine schedule as Trump and RFK Jr. fuel 2026 vaccine fight
The CDC, following a presidential directive and with a vaccine advisory panel appointed by HHS Secretary Robert F. Kennedy Jr., has for the first time reduced the universally recommended childhood vaccine schedule from roughly 17–18 to 11 diseases, removing rotavirus, hepatitis A and B (including delaying the newborn Hep B dose for some infants), RSV, meningococcal disease, seasonal influenza and COVID‑19 from universal recommendation — with some now limited to defined high‑risk groups and others left to shared clinical decision‑making between clinicians and parents. HHS says a review of 20 peer nations found the U.S. an “outlier” and frames the change as aligning with international practice and rebuilding trust, but leading medical experts and professional groups have criticized the bypassing of normal ACIP processes, warned of public‑health harms and litigation risks, even as officials say vaccine access and insurance coverage will continue.
đź“Ś Key Facts
- The CDC has overhauled the U.S. childhood vaccine schedule, cutting the list of universally recommended vaccines to those for 11 diseases (down from roughly 17–18 previously); the agency formally announced the changes and said they take effect immediately.
- The 11 vaccines that remain universally recommended cover: diphtheria, tetanus, acellular pertussis (whooping cough), Haemophilus influenzae type b (Hib), pneumococcal conjugate, polio, measles, mumps, rubella (MMR), human papillomavirus (HPV) and varicella.
- Vaccines for rotavirus, hepatitis A, hepatitis B, respiratory syncytial virus (RSV), meningococcal disease (ACWY/B), seasonal influenza and COVID‑19 are no longer on the universal schedule and have been either narrowed to children in defined high‑risk groups or made subject to clinician‑parent 'shared clinical decision‑making,' depending on the vaccine.
- The overhaul followed a December presidential memorandum from President Donald Trump directing HHS to benchmark U.S. guidance against 20 peer developed nations; HHS said its review found the U.S. an 'outlier' in number of diseases and doses recommended, a conclusion disputed by the American Academy of Pediatrics and other experts.
- HHS Secretary Robert F. Kennedy Jr. appointed the CDC vaccine advisory panel that voted on schedule changes in December (including delaying the hepatitis B birth dose to 2 months for infants of mothers who test negative); RFK Jr. and administration officials say the move 'protects children, respects families, and rebuilds trust in public health' and aligns U.S. guidance with international practice.
- Federal and private insurers will continue to cover the vaccines that were removed from the universal list, and officials say families who choose those vaccines will not face out‑of‑pocket costs and will retain access.
- Public‑health and medical groups — and experts including Michael Osterholm, Paul Offit and clinicians from the AAP and IDSA — sharply criticized the changes for circumventing the usual ACIP public process, lacking new public data or manufacturer input, and warned the rollback risks more hospitalizations and preventable deaths; analysts also flagged likely litigation and questions about vaccine liability protections.
- Reporting highlighted the historical benefits of some now‑de‑emphasized vaccines: CDC publications attribute hepatitis A, hepatitis B and rotavirus vaccines with preventing nearly 2 million hospitalizations and more than 90,000 deaths over the past 30 years; country comparisons (e.g., Denmark) were cited as illustrative of potential impacts.
- News outlets and analysts say the decision has already become a political flashpoint — described as a catalyst for a 'midterm vaccine war' — and is likely to make vaccines a prominent issue in the 2026 campaign cycle.
đź“Š Relevant Data
From 2016 to 2020, RSV-associated hospitalization rates were higher for Black, other race, and Hispanic children under 5 years old compared with non-Hispanic White children, with Hispanic children under 6 months having the highest rate among these groups.
Respiratory Syncytial Virus-Associated Hospitalizations Among Children <5 Years Old: 2016 to 2020 — Pediatrics
In the 2024-2025 RSV season, RSV prevention product coverage was 60.5% among infants born to Black, Middle Eastern, or North African women, compared to 83.7% for infants born to Asian mothers.
RSV-prevention products tied to lower infant hospitalization rates in 2024-25 — CIDRAP
From 2009-2019, age-adjusted flu-associated hospitalization rates were highest among Black persons (up to 4 times higher in children 0-4 years compared to non-Hispanic White children), followed by American Indian or Alaska Native and Hispanic persons.
New Study Identifies Racial and Ethnic Disparities in Severe Flu Outcomes — CDC
In week 50 of 2025, age-adjusted influenza hospitalization rates per 100,000 were 21.1 for non-Hispanic Black persons, 13.4 for American Indian or Alaska Native, 10.9 for Hispanic, 8.7 for non-Hispanic White, and 5.1 for Asian and/or Pacific Islander persons.
Weekly US Influenza Surveillance Report: Key Updates for Week 50, ending December 13, 2025 — CDC FluView
From 2020 to 2023, Black and Hispanic children were disproportionately more likely to be hospitalized for COVID-19 and experience severe disease compared with White and Asian or Pacific Islander children.
Pediatric COVID-19 Hospitalization Trends by Race and Ethnicity, 2020-2023 — JAMA Network Open
In 2020, marginalized populations had over twice the COVID-19 hospitalization rate relative to White patients, with highest age-adjusted mortality for Black, Hispanic, and Native American patients.
đź“° Sources (9)
The CDC just sidelined these childhood vaccines. Here's what they prevent.
New information:
- Explicitly enumerates the six vaccines that CDC has moved off the universal childhood schedule: hepatitis A, hepatitis B, rotavirus, respiratory syncytial virus (RSV), meningococcal disease, seasonal flu and COVID.
- Quantifies past benefits for three of those vaccines using CDC publications: hepatitis A, hepatitis B and rotavirus vaccines together have prevented nearly 2 million hospitalizations and more than 90,000 deaths in the past 30 years.
- Clarifies that all six sidelined vaccines remain covered by federal and private insurance and that parents who still choose them will not pay out of pocket.
- Details CDC’s remaining 11 universally recommended vaccines (MMR; whooping cough, tetanus, diphtheria; Hib; pneumococcal; polio; varicella; HPV), specifying what remains unchanged.
- Provides concrete comparative example from Denmark’s rotavirus policy, including an estimated 1,200–1,300 infant and toddler rotavirus hospitalizations annually in a country of 6 million, and notes this is similar to pre‑vaccine U.S. rates.
- Includes critical expert reaction from pediatric infectious‑disease specialist Paul Offit, who argues Denmark should emulate the previous U.S. standard and warns the new guidance shifts research and decision burdens to parents.
- Emphasizes that about 80% of children under two hospitalized with RSV have no identifiable risk factors, undermining the notion that high‑risk‑only recommendations will capture most severe cases.
- Reiterates HHS’s justification that the changes align with 'scientific review' and other developed nations’ schedules while noting experts say most European schedules are still closer to the old U.S. model.
Lawmakers split over Maduro's seizure. And, CDC cuts childhood vaccine schedule
New information:
- The CDC formally reduced its universally recommended childhood vaccines from 17 to 11 in a new schedule.
- Vaccines that had been recommended for all children — including rotavirus, hepatitis A and B, meningitis, and seasonal flu — are now treated more restrictively rather than as universal recommendations.
- NPR reports the CDC made these changes specifically in response to a December memo from President Trump directing health officials to align the U.S. childhood schedule with that of 'peer, developed countries' such as Germany and Japan.
- Dr. Sean O’Leary of the American Academy of Pediatrics told NPR that the new restrictions will lead to fewer children being vaccinated, with health consequences likely to emerge over years.
Trump administration sparks midterms vaccine war
New information:
- Axios explicitly frames the CDC schedule overhaul as a catalyst for a 'midterm vaccine war,' saying the move ensures vaccines will be 'front and center' in 2026 campaign discourse.
- The article notes that all vaccines previously recommended by the federal government will continue to be covered by insurers, even if removed from the universal recommendation list.
- RFK Jr. is quoted saying the U.S. is 'aligning the U.S. childhood vaccine schedule with international consensus' and claims the decision 'protects children, respects families, and rebuilds trust in public health,' sharpening the administration’s stated rationale.
- The piece reports administration officials’ argument that focusing on 'the most important diseases' will restore public trust, contrasted with critics saying the move is arbitrary and unsupported by new data.
- New, strongly worded criticism from leading medical and industry groups is quoted, including the presidents of the Infectious Diseases Society of America and the Biotechnology Innovation Organization and an AMA trustee emphasizing lack of transparent, evidence‑based process.
- Axios reports that the decision was announced without any new data and came exactly one month after Trump demanded a review of the schedule.
- The article flags expected litigation, including questions about whether removing vaccines from the recommended list might weaken or alter federal liability protections for manufacturers under existing vaccine injury frameworks.
What the overhaul of U.S. vaccine guidance means for public health
New information:
- PBS segment provides additional expert context via an interview with Dr. Sean O’Leary on what the CDC schedule changes mean for public health and clinical practice.
- It reiterates that flu and COVID-19 vaccines are now recommended only after consultation with a healthcare provider, not as blanket universal recommendations.
- It emphasizes that recommendations for hepatitis A, hepatitis B, RSV, and bacterial meningitis have been narrowed to children and others in higher‑risk groups, framing this as a major departure from past practice.
Health officials slash the number of vaccines recommended for all kids
New information:
- NPR provides additional process detail that the presidential memorandum ordering comparison with peer countries was issued Dec. 5, the same day vaccine advisers voted to drop universal newborn Hepatitis B at birth.
- The piece names Martin Kulldorf as 'chief science officer at a unit of HHS' and notes he briefly chaired CDC’s vaccine advisory committee last year, and identifies Tracy Beth Høeg as acting director of FDA’s Center for Drug Evaluation and Research.
- It documents that CDC and HHS officials confirmed the overhaul 'circumvented' the typical public ACIP process and lacked formal public comment or manufacturer input, sharpening concerns over transparency.
- NPR carries extensive on‑the‑record criticism from epidemiologist Michael Osterholm, who calls the elimination of long‑standing U.S. childhood vaccine recommendations without open data review 'radical,' 'dangerous,' and 'wildly irresponsible.'
- The article quotes HHS’s characterization of declining routine childhood vaccination (including measles vaccination) as evidence of eroding public trust, which they cite to justify the rollback.
Trump administration cuts number of vaccines it recommends for every child
New information:
- Explicit framing that this is the first time the U.S. has ever reduced the number of vaccines it recommends for every child, described as an 'unprecedented step.'
- Clarifies that the change follows a December directive from President Donald Trump ordering HHS to benchmark U.S. vaccine guidance against 20 peer nations and consider revisions to align with them.
- HHS says its review found the U.S. was an 'outlier' among 20 peer nations in both the number of vaccines and the number of doses recommended for all children.
- RFK Jr. is quoted saying the decision 'protects children, respects families, and rebuilds trust in public health,' sharpening the administration's stated rationale.
- Named expert Michael Osterholm of the Vaccine Integrity Project is quoted warning the move, including abandoning recommendations for influenza, hepatitis, rotavirus and changing HPV guidance without a transparent public process, will lead to more hospitalizations and preventable deaths.
- Article notes officials claim the overhaul will not cause families to lose access to or insurance coverage for vaccines, even though they are no longer universally recommended.
CDC announces new childhood vaccine recommendations for fewer shots
New information:
- CDC specifies that the universally recommended childhood vaccines now cover 11 diseases: diphtheria, tetanus, acellular pertussis, Hib, pneumococcal conjugate, polio, measles, mumps, rubella, HPV and varicella.
- CDC clarifies that RSV, hepatitis A, hepatitis B, dengue, and meningococcal ACWY/B are now recommended only for children in defined high‑risk categories.
- For children not in high‑risk groups, COVID‑19, influenza, meningococcal disease, hepatitis A and hepatitis B vaccinations are now subject to 'shared clinical decision‑making' between physicians and parents.
- The article reiterates that the CDC’s vaccine advisory panel, hand‑picked by HHS Secretary Robert F. Kennedy Jr., already voted in December to delay the hepatitis B birth dose to 2 months for infants of mothers who test negative for the virus.
- HHS says its review comparing 20 developed nations found the U.S. was a 'global outlier' in number of diseases and total recommended doses, a characterization disputed by the American Academy of Pediatrics, which says U.S. guidance is based on robust evidence and largely similar to peers.
- RFK Jr. is quoted saying the move 'protects children, respects families, and rebuilds trust in public health,' framing the changes as aligning the U.S. schedule with 'international consensus' and emphasizing transparency and informed consent.
CDC slashes childhood vaccine schedule in unprecedented overhaul following pandemic trust issues
New information:
- Confirms that the CDC has formally announced the overhauled childhood vaccine schedule and that the new guidelines are to take effect immediately.
- Restates in plain terms that the schedule now recommends vaccines for 11 diseases, down from 18 under the prior schedule, as the operative change parents and providers should expect.
- Attributes the policy shift more directly to a CDC-cited scientific assessment that ties the move to loss of trust during the COVID-19 pandemic, highlighting trust rebuilding as an explicit motive.